Tokyo, Aug. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058737) titled 'Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy of deucravacitinib in patients with psoriasis' on Aug. 8.
Study Type:
Observational
Primary Sponsor:
Institute - other
Condition:
Condition - psoriasis
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - This study investigates the relationships between plasma concentration and efficacy of deucravacitinib in patients with psoriasis.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria ...